Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Werewolf Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 39 | 38 | −1 |
| Shares | 20.9M | 24.0M | +3.10M (+14.8%) |
| Value | $42.8M | $62.5M | +$19.6M (+45.8%) |
New holders (7)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 120,936 | $314.4K | 0.00% |
| Schonfeld Strategic Advisors LLC | 73,418 | $190.9K | 0.00% |
| Edgewood Management LLC | 50,000 | $130.0K | 0.00% |
| Man Group plc | – | $117.3K | 0.00% |
| HBK Sorce Advisory LLC | 26,454 | $68.8K | 0.00% |
| Bailard, Inc. | 18,127 | $47.1K | 0.00% |
| FMR LLC | 2,100 | $5.46K | 0.00% |
Sold out (8)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 246,305 | $504.9K |
| Tejara Capital Ltd | 128,800 | $264.0K |
| Jacobs Levy Equity Management, Inc | 101,221 | $207.5K |
| Ergoteles LLC | 26,501 | $54.3K |
| Jane Street Group, LLC | 22,064 | $45.2K |
| Chicago Partners Investment Group LLC | 10,729 | $41.2K |
| Citadel Advisors LLC | 11,030 | $22.6K |
| Citigroup Inc | 74 | $152 |